Austrian Grand Prix follows Miami in extending F1 contract to 2041
The Austrian Grand Prix at the Red Bull Ring will stay on the calendar through 2041 after announcing on Sunday a contract extension that equals Miami as the longest in Formula One.
The current deal, last extended two years ago, ran to 2030.
The circuit in Spielberg is owned by the Austrian energy drinks company that owns Red Bull Racing, and has Dutch four times world champion Max Verstappen as their star driver, and Italy-based Racing Bulls.
Miami agreed a 10-year extension to 2041 last month.
Behind them, Bahrain has a deal to 2036, Melbourne to 2035, Saudi Arabia and Qatar to at least 2032.
'Austria has long been an incredibly special race for Formula One so it's fantastic we have secured the long-term future of a Grand Prix so deeply rooted in the sport's history,' said Formula One chief executive Stefano Domenicali.
ALSO READ | Formula 1 extends Canadian Grand Prix contract till 2035
Verstappen has won a record five times in Spielberg, a 4.3km circuit known for its picturesque backdrop and undulating layout.
The late Red Bull founder Dietrich Mateschitz, whose son Mark is now at the helm, invested heavily in renovating the circuit.
'I am delighted that Formula One will remain at the Red Bull Ring for many years to come. I am proud to continue my father's legacy,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
31 minutes ago
- Time of India
Shocking! Carlos Sainz's F1 car catches fire at Austrian GP — Watch video
The Austrian Grand Prix's Sunday start faced a 10-minute delay when Carlos Sainz's Williams failed to leave the grid during the formation lap. Marshals pushed Sainz's car, and he pursued the field, planning to start from the pit lane until his rear brakes caught fire. Tired of too many ads? go ad free now The race was shortened to 70 laps. Go Beyond The Boundary with our YouTube channel. Sainz had to withdraw from the race as his car couldn't be repaired quickly enough. Watch: Race conditions were challenging with air temperatures reaching 32 degrees Celsius and track temperatures at 54 degrees. "I cannot tell you the temperature of the seat," said two-time champion Fernando Alonso of Aston Martin as he waited for the re-start. "It's maybe 200 degrees!" Lando Norris secured victory at the Austrian Grand Prix, successfully defending against his McLaren teammate Oscar Piastri throughout the race. The early stages saw Norris and Piastri fighting for the lead, with Piastri briefly taking first place before Norris reclaimed it. Piastri's aggressive move nearly resulted in a collision. Poll What impact do you think the high temperatures had on driver performance? Significant impact, it influenced the race. Minimal impact, they handled it well. Piastri lost positions during pit stops and was forced onto grass by Alpine's Franco Colapinto while navigating traffic. He recovered and closed the gap to Norris but couldn't complete an overtake. "We had a great battle, that's for sure," Norris said later. "A lot of stress, but a lot of fun. A nice battle, so well done to Oscar." Over the radio, Norris described it as a "beautiful one-two" finish for the team. The championship battle has become a McLaren affair after Max Verstappen's race ended following a collision with Kimi Antonelli on lap one. Piastri leads Norris by 15 points, while Verstappen remains third, 61 points behind. Piastri expressed regret about the near-collision with Norris and his brief time in the lead. Tired of too many ads? go ad free now "I hope it was good watching because it was pretty hard work from the car," Piastri said. "I tried my absolute best and probably could have done a better job when I just got ahead momentarily. It was a good battle, a bit on the edge at times." Ferrari claimed the next two positions, with Charles Leclerc finishing third, marking his third podium in four races. Lewis Hamilton, his teammate, secured fourth place. Mercedes driver George Russell, fresh from his Canadian Grand Prix victory, finished fifth. Racing Bulls' Liam Lawson achieved his season-best result in sixth place. Aston Martin's Fernando Alonso managed to keep Sauber's Gabriel Bortoleto behind him for seventh place. Nico Hulkenberg in the second Sauber took ninth, while Haas driver Esteban Ocon completed the points positions in tenth.
&w=3840&q=100)
Business Standard
39 minutes ago
- Business Standard
Torrent Pharma to acquire JB Pharma from KKR at ₹25,689 cr valuation
In one of the largest pharma deals in the domestic market in recent years, Ahmedabad-based Torrent Pharmaceuticals will acquire a controlling stake in investment firm KKR-backed JB Chemicals and Pharmaceuticals (known as JB Pharma) at an equity valuation of ₹25,689 crore, which will be followed by the merger of the two entities. The deal will be executed in two phases — acquisition of the 46.39 per cent stake held by KKR in JB Pharma at ₹1,600 per share, amounting to ₹11,917 crore, followed by a mandatory open offer to acquire up to 26 per cent of JB Pharma shares from public shareholders at ₹1,639.18 per share. 'In addition to the above, Torrent has also expressed its intent to acquire up to 2.8 per cent of equity shares from certain employees of JB Pharma at the same price per share as KKR,' the company said in a statement on Sunday. The next step in the deal will be a merger between Torrent Pharma and JB Pharma through a scheme of arrangement, under which every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharma. The boards of directors of both companies have approved this arrangement. KKR had acquired 54 per cent of JB Pharma in July 2020 from the promoters and founders, the Mody family, for approximately ₹3,100 crore (or ₹745 per share). It sold a part of its stake in March this year through block deals for ₹1,459.8 crore. KKR has earned more than five times on its investment, with around 36 per cent gross IRR. For instance, Torrent Pharma has previously indicated plans to increase its medical representative (MR) strength by 23 per cent by the end of FY26, and the acquisition can aid in manpower augmentation. Torrent Pharma holds a 3.74 per cent share in the domestic market (according to Pharmarack, May 2025), while JB Pharma commands a 1.12 per cent share. Further, consolidation in key international markets is expected to offer greater scalability. Samir Mehta, executive chairman of Torrent Pharma, said they want to build on JB Pharma's heritage and platform for the future. 'Torrent's deep India presence and JB Pharma's fast-growing India business, combined with the CDMO and international footprint, offer immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market and builds a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.' Torrent has previously taken the inorganic route to grow its business and enter newer segments — in 2013, it acquired Elder Pharma's India-branded business; followed by the dermaceutical business of Zyg Pharma in 2015 and the API plant of Glochem Industries in 2016. Among other major deals, it bought the India-branded business of Unichem in 2017. Its last major acquisition was of skin-care products from Curatio Healthcare in 2022. Torrent Pharma is a highly domestic-focused company, drawing around 55 per cent of its consolidated revenues from the domestic formulations business. India sales grew by 13 per cent in FY25 to ₹6,393 crore. While the company has been outperforming industry growth in the domestic market, it is also planning to increase MR strength by 23 per cent by FY26-end. Torrent has a strong presence in the cardiovascular, gastrointestinal and neurology segments. JB too has prominent cardiac and gastro brands like Cilacar, Metrogyl and Rantac. Torrent is also working on launching GLP-1 products as a day-one launch in FY26. Analysts expect a 15 per cent sales CAGR in domestic formulations for Torrent Pharma over FY25–27. Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific private equity at KKR, and CEO of KKR India, said: 'JB Pharma's transformation under our stewardship is a testament to KKR's ability to scale high-quality companies.' Nikhil Chopra, chief executive officer and whole-time director of JB Pharma, pointed out that over the past five years, the company has emerged as one of India's fastest-growing pharmaceutical players. 'We have built a strong foundation to deliver market-leading growth, as well as consistent improvement in profitability in the medium and long term. As we now enter a new chapter alongside Torrent Pharmaceuticals, we are confident that the combined strengths of our organisations will unlock greater opportunities to enhance healthcare access across our markets,' Chopra said. JB Pharma posted 12 per cent revenue growth in FY25 to ₹3,918 crore, while its EBITDA rose 16 per cent to ₹1,087 crore, and PAT increased 19 per cent to ₹660 crore. Notably, KKR Private equity has invested $2 billion in India in 2024 and recently invested $600 million in Manipal Group via its private credit arm.
Hindustan Times
40 minutes ago
- Hindustan Times
From July 1, reservation charts to be released 8 hours before train departure
New Delhi: The Indian Railways on Sunday said that it would prepare the reservation chart eight hours before the train departure time, starting from July 1. The railways also said that it will introduce a Modern Passenger Reservation System (PRS) by December this year. (Representational image) As of now, the chart that determines whether waitlisted tickets are confirmed is prepared and released just four hours prior to the train's departure time. The move is expected to give passengers more clarity and time to make alternative travel arrangements in case their train tickets do not get confirmed. '..Wherever passengers are coming from a nearby area to catch the train, this uncertainty can cause serious problems. To remove this uncertainty, the railway board has proposed preparing the reservation chart eight hours before the departure,' a statement from the railways said. 'The Railway Minister agreed with this proposal and directed the board to start implementing this in phases so that there is no disruption,' it added. 'The passengers will get the first update on waitlist status well in advance. It will benefit passengers travelling from remote locations or suburbs of major cities for catching long distance trains. It will also provide more time to make alternative arrangements in case the wait list is not confirmed,' the railways said, adding that it will reduce uncertainties for passengers with waitlist tickets. The railways also said that it will introduce a Modern Passenger Reservation System (PRS) by December this year. Railway minister Ashwani Vaishnaw reviewed the upgradation of the passenger reservation system, it said, adding that the project is being executed for the last few months by the Centre For Railway Information Systems (CRIS). 'The new upgraded PRS design to handle ten times the current load. It will significantly enhance the ticket booking capacity…it will allow over 1.5 lakh ticket bookings per minute. This will be an increase of roughly five times from 32,000 tickets per minute in the current PRS,' it said. 'The ticket enquiry capacity will jump ten times from 4 lakh to over 40 lakh per enquiry will be possible in a minute time. The new PRS also has a multilingual and user-friendly booking and enquiry interface,' the statement added. Passengers will be able to submit their choice of seat and see the fare calendar. It also has integrated facilities for Divyangjan, students, patients, it said. This comes after the railways announced that only authenticated users will be allowed to book Tatkal tickets on IRCTC website and mobile app beginning July 1 and that an OTP-based authentication will be done for Tatkal bookings from the end of July. 'The authentication will be done using Aadhaar or any other verifiable Government ID available in the user's DigiLocker account,' the statement concluded.
